Altis AI Imaging Biomarker Outperforms RECIST for Predicting Survival in Lung Cancer Trials

Altis AI Imaging Biomarker Outperforms RECIST for Predicting Survival in Lung Cancer Trials | Altis Labs | LifeScienceSaaS